SNY Stock Summary and Trading Ideas (Sanofi - American Depositary Shares | NASDAQ:SNY)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest revenue generator, Dupixent, accounts for approximately 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.

As of December 31, 2025, SNY stock price declined to $48.46 with 753,784 million shares trading.

SNY has a beta of 0.66, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.17 to the broad based SPY ETF.

SNY has a market cap of $117.41 billion. This is considered a Large Cap stock.

Last quarter Sanofi - American Depositary Shares reported $15 billion in Revenue and $1.70 earnings per share. This beat revenue expectation by $78 million and exceeded earnings estimates by $.10.

In the last 3 years, SNY traded as high as $60.12 and as low as $42.63.

The top ETF exchange traded funds that SNY belongs to (by Net Assets): PVAL, PPH, FVD, PID, AVDE.

SNY has underperformed the market in the last year with a price return of +5.1% while the SPY ETF gained +17.6%. However, in the short term, SNY had mixed performance relative to the market. It has outperformed in the last 3 months, returning +2.7% vs +2.7% return in SPY. But in the last 2 weeks, SNY shares have been beat by the market, returning +0.7% compared to an SPY return of +1.9%.

SNY support price is $48.23 and resistance is $49.25 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.